David C. Myles

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David C. Myles:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. CH. DISCOV. & NON-CLIN DEV OFF Common Stock 598K $5.62M $9.39 11 Dec 2024 Direct
Olema Pharmaceuticals, Inc. CH. DISCOV. & NON-CLIN DEV OFF Common Stock 155K $1.45M $9.39 09 Dec 2024 Indirect
Olema Pharmaceuticals, Inc. CH. DISCOV. & NON-CLIN DEV OFF Stock Option (Right to Buy) 205K 28 Feb 2025 Direct

Insider Reports Filed by David C. Myles

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OLMA Olema Pharmaceuticals, Inc. 28 Feb 2025 1 $0 4 CH. DISCOV. & NON-CLIN DEV OFF 03 Mar 2025, 16:20
OLMA Olema Pharmaceuticals, Inc. 09 Dec 2024 4 -$235K 4 CH. DISCOV. & NON-CLIN DEV OFF 11 Dec 2024, 19:56
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2024 1 $0 4 CH. DISCOV. & NON-CLIN DEV OFF 05 Feb 2024, 17:30
OLMA Olema Pharmaceuticals, Inc. 20 Nov 2023 4 -$196K 4 CH. DISCOV. & NON-CLIN DEV OFF 22 Nov 2023, 19:00
OLMA Olema Pharmaceuticals, Inc. 08 Nov 2023 1 -$3.52K 4 CH. DISCOV. & NON-CLIN DEV OFF 13 Nov 2023, 17:30
OLMA Olema Pharmaceuticals, Inc. 01 Nov 2023 3 -$161K 4 CH. DISCOV. & NON-CLIN DEV OFF 03 Nov 2023, 21:39
OLMA Olema Pharmaceuticals, Inc. 19 Sep 2023 1 -$253K 4 CH. DISCOV. & NON-CLIN DEV OFF 21 Sep 2023, 17:00
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 Chief Development Officer 02 Feb 2023, 16:32
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 CHIEF DEVELOPMENT OFFICER 03 Feb 2022, 18:15
OLMA Olema Pharmaceuticals, Inc. 10 Dec 2021 1 -$103K 4 CHIEF DEVELOPMENT OFFICER 14 Dec 2021, 15:03